Development of Colorectal-Targeted Dietary Supplement Tablets Containing Natural Purple Rice Bran Oil as a Colorectal Chemopreventive

Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the r...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients Vol. 10; no. 4; p. 444
Main Authors: Sirithunyalug, Busaban, Saenjum, Chalermpong, Charumanee, Suporn, Sivamaruthi, Bhagavathi Sundaram, Chaiyasut, Chaiyavat, Sirithunyalug, Jakkapan, Tipduangta, Pratchaya
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 04-04-2018
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao' Gam Leum-Phua (KGLP), Khao' Gam Boung (KGB), Khao' Gam Thor (KGT), Khao' Gam Pah E-Kaw (KGPEK), and Khao' Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit L100 and Eudragit NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system.
AbstractList Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao' Gam Leum-Phua (KGLP), Khao' Gam Boung (KGB), Khao' Gam Thor (KGT), Khao' Gam Pah E-Kaw (KGPEK), and Khao' Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit®L100 and Eudragit® NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil® was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system.
Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao’ Gam Leum-Phua (KGLP), Khao’ Gam Boung (KGB), Khao’ Gam Thor (KGT), Khao’ Gam Pah E-Kaw (KGPEK), and Khao’ Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit®L100 and Eudragit® NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil® was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system.
Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao' Gam Leum-Phua (KGLP), Khao' Gam Boung (KGB), Khao' Gam Thor (KGT), Khao' Gam Pah E-Kaw (KGPEK), and Khao' Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit L100 and Eudragit NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system.
Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao’ Gam Leum-Phua (KGLP), Khao’ Gam Boung (KGB), Khao’ Gam Thor (KGT), Khao’ Gam Pah E-Kaw (KGPEK), and Khao’ Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit ® L100 and Eudragit ® NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil ® was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system.
Author Saenjum, Chalermpong
Sivamaruthi, Bhagavathi Sundaram
Sirithunyalug, Jakkapan
Tipduangta, Pratchaya
Sirithunyalug, Busaban
Charumanee, Suporn
Chaiyasut, Chaiyavat
AuthorAffiliation 1 Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand; busaban.s@cmu.ac.th (B.S.); chalermpong.saenjum@gmail.com (C.S.); chsuporn@gmail.com (S.C.); sivasgene@gmail.com (B.S.S.); chaiyavat@gmail.com (C.C.); Jakkapan.S@cmu.ac.th (J.S.)
2 Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand
3 Innovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University; Chiang Mai 50200, Thailand
AuthorAffiliation_xml – name: 1 Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand; busaban.s@cmu.ac.th (B.S.); chalermpong.saenjum@gmail.com (C.S.); chsuporn@gmail.com (S.C.); sivasgene@gmail.com (B.S.S.); chaiyavat@gmail.com (C.C.); Jakkapan.S@cmu.ac.th (J.S.)
– name: 2 Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand
– name: 3 Innovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University; Chiang Mai 50200, Thailand
Author_xml – sequence: 1
  givenname: Busaban
  surname: Sirithunyalug
  fullname: Sirithunyalug, Busaban
  email: busaban.s@cmu.ac.th, busaban.s@cmu.ac.th
  organization: Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand. busaban.s@cmu.ac.th
– sequence: 2
  givenname: Chalermpong
  surname: Saenjum
  fullname: Saenjum, Chalermpong
  email: chalermpong.saenjum@gmail.com, chalermpong.saenjum@gmail.com
  organization: Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand. chalermpong.saenjum@gmail.com
– sequence: 3
  givenname: Suporn
  surname: Charumanee
  fullname: Charumanee, Suporn
  email: chsuporn@gmail.com
  organization: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. chsuporn@gmail.com
– sequence: 4
  givenname: Bhagavathi Sundaram
  orcidid: 0000-0002-5499-8350
  surname: Sivamaruthi
  fullname: Sivamaruthi, Bhagavathi Sundaram
  email: sivasgene@gmail.com, sivasgene@gmail.com
  organization: Innovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University; Chiang Mai 50200, Thailand. sivasgene@gmail.com
– sequence: 5
  givenname: Chaiyavat
  surname: Chaiyasut
  fullname: Chaiyasut, Chaiyavat
  email: chaiyavat@gmail.com, chaiyavat@gmail.com
  organization: Innovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University; Chiang Mai 50200, Thailand. chaiyavat@gmail.com
– sequence: 6
  givenname: Jakkapan
  surname: Sirithunyalug
  fullname: Sirithunyalug, Jakkapan
  email: Jakkapan.S@cmu.ac.th, Jakkapan.S@cmu.ac.th
  organization: Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand. Jakkapan.S@cmu.ac.th
– sequence: 7
  givenname: Pratchaya
  surname: Tipduangta
  fullname: Tipduangta, Pratchaya
  email: P.Tipduangta@gmail.com
  organization: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. P.Tipduangta@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29617306$$D View this record in MEDLINE/PubMed
BookMark eNpdkt9uFCEUhyemxtbaGx_AkHhjTFYZYGC4MdGtf5o01uh6Tc4yZ7ZsWJgyzCY-gO8t2611KzeHwJeP3yHnaXUUYsCqel7TN5xr-jZMNaWCCiEeVSeMKjaTUvCjg_1xdTaOa7pbiirJn1THTMtacSpPqt_nuEUfhw2GTGJP5tHHhDaDny0grTBjR84dZki_yI9pGDzekgtYesxjwUMGF1xYka-QpwSefJtSoch3Z5F8SBDIlfMERgIHbjK_xk0cUnk7ZLfFZ9XjHvyIZ3f1tPr56eNi_mV2efX5Yv7-cmYb3uYZEyAVb6jqWqZby6FpG0lFJ_u65roDrWzHhdKaQYusp6K1qq5LkVK1VlJ-Wl3svV2EtRmS25S-TARnbg9iWhlI2VmPhklbW4aAloKgetlS2Sip-qZbQmctFte7vWuYlhvsbOmktP9A-vAmuGuzilvTaCEZ00Xw6k6Q4s2EYzYbN1r0HgLGaTSMMlYz3bS73C__Q9dxSqF8VaEEVUq1VBTq9Z6yKY5jwv4-TE3NbljMv2Ep8IvD-Pfo39HgfwA5GLwf
CitedBy_id crossref_primary_10_3390_molecules26123565
crossref_primary_10_1080_23312009_2018_1529259
crossref_primary_10_1002_efd2_86
crossref_primary_10_1111_jfbc_13487
crossref_primary_10_3390_antiox9060493
crossref_primary_10_3390_nu15112503
crossref_primary_10_1002_ptr_8131
crossref_primary_10_3390_molecules26175234
crossref_primary_10_5937_arhfarm72_40329
crossref_primary_10_3390_antiox11020305
crossref_primary_10_1208_s12249_020_01765_2
crossref_primary_10_29169_1927_5951_2019_09_04_2
crossref_primary_10_1016_j_trac_2020_115942
crossref_primary_10_3390_antiox10071144
Cites_doi 10.1016/S0140-6736(10)60353-4
10.3310/hta14320
10.1016/j.supflu.2010.08.004
10.1038/35094017
10.1016/j.biopha.2009.09.018
10.1111/apt.13857
10.1016/S0378-8741(02)00205-2
10.1016/S1461-5347(99)00151-0
10.1038/bjp.2008.268
10.1038/sj.bjc.6603539
10.1093/carcin/bgp205
10.1016/S0169-409X(02)00071-6
10.1073/pnas.90.5.1771
10.1021/jf981175j
10.1021/jf034466n
10.2131/jts.16.191
10.1111/j.2042-7158.1997.tb06761.x
10.1590/1678-457X.6730
10.1089/jmf.2009.1118
10.1016/j.foodchem.2008.04.031
10.1016/0278-6915(92)90135-8
10.1007/s10561-006-9028-6
10.1002/(SICI)1097-0215(20000515)86:4<553::AID-IJC18>3.0.CO;2-9
10.1021/jf0490293
10.1016/0003-2697(76)90527-3
10.1021/jf102224b
10.1016/j.bbrc.2007.04.178
10.1002/mnfr.200700418
ContentType Journal Article
Copyright Copyright MDPI AG 2018
2018 by the authors. 2018
Copyright_xml – notice: Copyright MDPI AG 2018
– notice: 2018 by the authors. 2018
DBID NPM
AAYXX
CITATION
3V.
7TS
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/nu10040444
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Physical Education Index
Health & Medical Complete (ProQuest Database)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database (Proquest) (PQ_SDU_P3)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
Physical Education Index
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2072-6643
ExternalDocumentID oai_doaj_org_article_26c1c2eaec0a409b8065767f5dbadcce
10_3390_nu10040444
29617306
Genre Journal Article
GroupedDBID ---
3V.
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAWTL
ABUWG
ACIWK
ACPRK
ADRAZ
AENEX
AFKRA
AFRAH
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
APEBS
ATCPS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
DIK
E3Z
EBD
ECGQY
EIHBH
ESTFP
EYRJQ
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IPNFZ
KQ8
LK8
M0K
M1P
M48
M7P
MODMG
M~E
NPM
OK1
P2P
P6G
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
UKHRP
AAYXX
CITATION
7TS
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
AFPKN
ID FETCH-LOGICAL-c538t-24a673507d8298c3a585604d6f1139da97cd347992a8e2f048c7110486678c603
IEDL.DBID RPM
ISSN 2072-6643
IngestDate Tue Oct 22 15:15:54 EDT 2024
Tue Sep 17 21:06:26 EDT 2024
Fri Oct 25 02:07:59 EDT 2024
Thu Oct 10 22:21:38 EDT 2024
Thu Nov 21 23:02:57 EST 2024
Wed Oct 16 00:59:04 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords delivery system for dietary supplement
gastrointestinal inflammatory diseases
γ-oryzanol
purple rice bran oil
anti-inflammatory activity
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c538t-24a673507d8298c3a585604d6f1139da97cd347992a8e2f048c7110486678c603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5499-8350
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946229/
PMID 29617306
PQID 2040777804
PQPubID 2032353
ParticipantIDs doaj_primary_oai_doaj_org_article_26c1c2eaec0a409b8065767f5dbadcce
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5946229
proquest_miscellaneous_2022129580
proquest_journals_2040777804
crossref_primary_10_3390_nu10040444
pubmed_primary_29617306
PublicationCentury 2000
PublicationDate 2018-04-04
PublicationDateYYYYMMDD 2018-04-04
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-04
  day: 04
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Nutrients
PublicationTitleAlternate Nutrients
PublicationYear 2018
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References 17499610 - Biochem Biophys Res Commun. 2007 Jun 29;358(2):615-9
18587421 - Br J Pharmacol. 2008 Sep;155(2):198-209
11097223 - Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1163-70
17094019 - Cell Tissue Bank. 2007;8(3):179-86
20594533 - Health Technol Assess. 2010 Jun;14 (32):1-206
20731354 - J Agric Food Chem. 2010 Sep 22;58(18):10007-15
27859394 - Aliment Pharmacol Ther. 2017 Jan;45(2):193-204
17211473 - Br J Cancer. 2007 Jan 29;96(2):248-54
12413723 - J Ethnopharmacol. 2002 Nov;83(1-2):153-9
12926869 - J Agric Food Chem. 2003 Aug 27;51(18):5271-7
1798065 - J Toxicol Sci. 1991 Nov;16(4):191-202
10797271 - Int J Cancer. 2000 May 15;86(4):553-60
942051 - Anal Biochem. 1976 May 7;72:248-54
20041774 - J Med Food. 2009 Dec;12(6):1213-20
8446589 - Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1771-5
11900248 - Nat Rev Cancer. 2001 Oct;1(1):11-21
9120760 - J Pharm Pharmacol. 1997 Jan;49(1):105-7
15686439 - J Agric Food Chem. 2005 Feb 9;53(3):816-22
19748925 - Carcinogenesis. 2010 Apr;31(4):533-42
15816542 - Anticancer Res. 2005 Jan-Feb;25(1A):225-33
12363433 - Adv Drug Deliv Rev. 2002 Oct 4;54(6):825-50
10552553 - J Agric Food Chem. 1999 Jul;47(7):2724-8
19954924 - Biomed Pharmacother. 2010 May;64(5):327-32
18481320 - Mol Nutr Food Res. 2008 Aug;52(8):921-9
10322382 - Pharm Sci Technolo Today. 1999 May;2(5):197-204
1544605 - Food Chem Toxicol. 1992 Jan;30(1):41-8
20304247 - Lancet. 2010 Mar 20;375(9719):1030-47
ref35
ref12
ref15
ref14
ref31
ref30
ref11
ref33
ref2
Rubinstein (ref34) 2006
ref1
ref17
Malekian (ref13) 2000
ref16
ref19
ref18
(ref32) 2016; Volume 1
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref27
Hudson (ref5) 2000; 9
ref29
ref8
ref9
ref4
ref3
Srisala (ref7) 2009; 24
ref6
Buecher (ref28) 2005; 25
Saenjum (ref10) 2012; 6
References_xml – ident: ref1
  doi: 10.1016/S0140-6736(10)60353-4
– volume: Volume 1
  start-page: 1749
  year: 2016
  ident: ref32
  article-title: [1216] TABLET FRIABILITY
– volume: 25
  start-page: 225
  year: 2005
  ident: ref28
  article-title: Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines
  publication-title: Anticancer Res.
  contributor:
    fullname: Buecher
– ident: ref3
  doi: 10.3310/hta14320
– ident: ref14
  doi: 10.1016/j.supflu.2010.08.004
– ident: ref30
  doi: 10.1038/35094017
– ident: ref31
  doi: 10.1016/j.biopha.2009.09.018
– start-page: 3
  year: 2006
  ident: ref34
  article-title: Gastrointestinal anatomy, physiology and permeation pathways
  contributor:
    fullname: Rubinstein
– ident: ref2
  doi: 10.1111/apt.13857
– ident: ref17
  doi: 10.1016/S0378-8741(02)00205-2
– ident: ref33
  doi: 10.1016/S1461-5347(99)00151-0
– ident: ref23
  doi: 10.1038/bjp.2008.268
– ident: ref9
  doi: 10.1038/sj.bjc.6603539
– ident: ref26
  doi: 10.1093/carcin/bgp205
– ident: ref35
  doi: 10.1016/S0169-409X(02)00071-6
– ident: ref27
  doi: 10.1073/pnas.90.5.1771
– ident: ref15
  doi: 10.1021/jf981175j
– ident: ref18
  doi: 10.1021/jf034466n
– ident: ref11
  doi: 10.2131/jts.16.191
– ident: ref20
  doi: 10.1111/j.2042-7158.1997.tb06761.x
– ident: ref16
  doi: 10.1590/1678-457X.6730
– ident: ref19
  doi: 10.1089/jmf.2009.1118
– ident: ref4
  doi: 10.1016/j.foodchem.2008.04.031
– volume: 24
  start-page: 81
  year: 2009
  ident: ref7
  article-title: Effects of bran extracts from thai molecular breeding rices on growth and apoptosis in human promyelocytic leukemia cells
  publication-title: Thai J. Toxicol.
  contributor:
    fullname: Srisala
– ident: ref12
  doi: 10.1016/0278-6915(92)90135-8
– ident: ref22
  doi: 10.1007/s10561-006-9028-6
– ident: ref29
  doi: 10.1002/(SICI)1097-0215(20000515)86:4<553::AID-IJC18>3.0.CO;2-9
– ident: ref6
  doi: 10.1021/jf0490293
– ident: ref21
  doi: 10.1016/0003-2697(76)90527-3
– volume: 9
  start-page: 1163
  year: 2000
  ident: ref5
  article-title: Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells
  publication-title: Cancer Epidemiol. Biomark. Prev.
  contributor:
    fullname: Hudson
– ident: ref25
  doi: 10.1021/jf102224b
– ident: ref8
  doi: 10.1016/j.bbrc.2007.04.178
– start-page: 1
  year: 2000
  ident: ref13
  contributor:
    fullname: Malekian
– volume: 6
  start-page: 1070
  year: 2012
  ident: ref10
  article-title: Antioxidant and anti-inflammatory activities of gamma-oryzanol rich extracts from thai purple rice bran
  publication-title: J. Med. Plants Res.
  contributor:
    fullname: Saenjum
– ident: ref24
  doi: 10.1002/mnfr.200700418
SSID ssj0000070763
Score 2.2946372
Snippet Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and...
Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn’s disease and...
Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn&amp;rsquo;s disease...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 444
SubjectTerms anti-inflammatory activity
Anti-inflammatory agents
Antioxidants
Bioactive compounds
Carbon dioxide
Coating
Coatings
Colorectal cancer
Colorectal carcinoma
Cultivars
Cyclooxygenase-2
delivery system for dietary supplement
Dietary fiber
Dietary supplements
gastrointestinal inflammatory diseases
Health risks
Inflammatory bowel diseases
Intestine
Oils & fats
Oryza
Powder
purple rice bran oil
Rice bran
Rice bran oil
Risk factors
Tablets
Tocopherol
Tocopherols
Ulcerative colitis
Vegetable oils
γ-oryzanol
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BT1wQpQ8CBQ0q6i1q4jh2fOxTPRUEi9Rb5PghVlqyqLuL1B_Q_82Ms112UaVeuMZW4nhmPPPZ428APnUEtyI5rtzWPubSSpMb733eUEOQ0QSfyHSuvunrm-b8gmlyVqW-OCdsoAceJu5YKFc6EWxwhSUs0vFBoFY61r6z3rmQVt9CrYGpIfDVBNCrgY-0Ilx_3C-YG43Z0TY8UCLqfyy6_DdJcs3rXL6Cl8twEU-GYW7Ds9C_hp2TnqDyzzs8wpTAmXbGd-B-LQEIpxHP6DmvZ3aSj1K-d_B4Pg5ze3uHqZhn2hnEEV-ems-QeaqGchF4bRMbB34hKUwCfqXFBE_JqeHn8QTtDO3au5EpB7iUSkqc_B124fvlxejsKl9WWcgdLXbzXEirdEVhoW-EaVxlCUCoQnoVS4oOvTXaeb5uaoRtgohk8U5TzCAbRX7OqaLag61-2oc3gGUk9FF2JOsQuZB1p7zQZZSuLJ2Xtcjg8GHm218DmUZLIITl0_6VTwanLJRVDybATg9ILdqlWrRPqUUGBw8ibZdWOWsFfUBrplzK4OOqmeyJD0lsH6YL7iPIm5u6KTLYHzRgNRJhKN4jjJWB3tCNjaFutvTjH4mzuzZSCWHe_o9_ewcvKGxrUv6QPICt-e0ivIfnM7_4kKzgD0NxEJM
  priority: 102
  providerName: Directory of Open Access Journals
Title Development of Colorectal-Targeted Dietary Supplement Tablets Containing Natural Purple Rice Bran Oil as a Colorectal Chemopreventive
URI https://www.ncbi.nlm.nih.gov/pubmed/29617306
https://www.proquest.com/docview/2040777804
https://search.proquest.com/docview/2022129580
https://pubmed.ncbi.nlm.nih.gov/PMC5946229
https://doaj.org/article/26c1c2eaec0a409b8065767f5dbadcce
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xPXFBQHkEysoIxC3djePE8bHdtipClAoWiVvk-AEr7WarfSD1B_R_d8ZJlizixDXOw8qMPfPZn78BeF8h3PIYuGKdWR8LLVSsrLVxgQ1OeOVsENO5_CavfhRn5ySTk3VnYQJp31Sz43q-OK5nvwK38mZhRh1PbHT9eZIpkXOuRgMYYG7Yg-hNzisRm6eNFGmKkH5Ub0kWjYTRSPpXYcxOqcBRLw4Fuf5_5Zh_UyV7sefiMTxqk0Z20nTuCTxw9VM4PKkRMC9u2QcWaJxhffwQ7no0ILb0bILXaVbT83gaWN_OsrOZ2-jVLQslPcP6IJvSEarNmpFaVVM0gl3poMnBrtEWc8e-4pTCTjG0sS-zOdNrpnvvZiQ8QAVVAn3yt3sG3y_Op5PLuK21EBuc8jYxFzqXKSaHtuCqMKlGGJGPhc19gjmi1UoaS4dOFdeF4x7HvZGYOYgix2hn8nH6HA7qZe1eAks8YpCkQos7T-Wsq9xymXhhksRYkfEI3nV_vrxpJDVKhCJkqvKPqSI4JaPs7iAZ7HBhufpZts5Q8twkhjvtzFgjUK1ol1jm0me20tYYF8FRZ9KyHZvrkuMHpCThpQje7ppxVNFWia7dckv3cIzpKivGEbxoPGDXk86DIpB7vrHX1f0WdOSg3N067qv_fvI1PMSMrQjUIXEEB5vV1r2Bwdpuh4gHPn4ahjWFYRgR95U-EYc
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB3RcoALUAolUIoRiFu6iePE8bHdtlpEu1SwSNwixx_tSrvZaj-Q-gP434ydZJutOPVqO4mVGXvmJc9vAD6XCLcsBq5QptqGTDIRCq11mGOHYVYY7cV0Bj_58Hd-cupkctL2LIwn7atyfFhNpofV-NpzK2-mqtfyxHqXF_1UsIxS0duCx7heo6gD0uuslyM6T2ox0gRBfa9aOWE0J43mxH8FRu3ElTjqRCIv2P-_LPM-WbITfc6eP3DeL-BZk26So7p7Bx6Z6iXsHlUItae35AvxBFD_ZX0X_nYIRGRmSR_b3X4oJ-HI88WNJidjs5TzW-KLgfovi2TkDl8tF8TpXNXlJshQejUPcolWnBjyAzcjcoxBkXwfT4hcENm5N3GSBa4Uiyde_jGv4NfZ6ag_CJsqDaHCl78MKZMZTzCt1DkVuUokApAsYjqzMWaXWgqutDuuKqjMDbW4YyiOOQfLM4yTKouS17BdzSrzBkhsEb3EJfqKsa4QdplpymPLVBwrzVIawKfWYsVNLcZRIIhxJi7uTBzAsTPmeoQT0PYNs_lV0ZijoJmKFTXSqEgixC3d_2WecZvqUmqlTAD7rSsUzapeFBQfwLmTbArg47ob16P7ySIrM1u5MRSzAZHmUQB7teesZ9J6XgB8w6c2prrZg67kNb8b13n74Cs_wJPB6OK8OP86_PYOnmLel3sCEtuH7eV8Zd7D1kKvDvxK-gcvfCUm
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB6xi4S48FpYAgsYgbhlkzhOHB93260WAaWCInGLHD-gUptWfay0P2D_N2MnLSniBNfYSSzN2DOf_fkbgLcVwi2LgSuUmbYhk0yEQmsdFthgmBVGezGdy698-L3oXziZnF2pL0_aV9XktJ7OTuvJT8-tXMxUtOWJRaNPvUywnFIRLbSNDuA2ztmYdoB6k_lyROhpI0iaIrCP6o0TR3PyaE4AWGDkTl2Zo0408qL9f8s0_yRMdiLQ4P5_jP0B3GvTTnLWdHkIt0z9CI7OaoTcs2vyjngiqN9hP4KbDpGIzC3p4XO3LsppOPa8caNJf2LWcnlNfFFQv8NIxu4S1npFnN5VU3aCDKVX9SAjtObUkC-4KJFzDI7k82RK5IrIzreJky5wJVk8AfPKPIZvg4tx7zJsqzWECg2wDimTOU8xvdQFFYVKJQKRPGY6twlmmVoKrrS7tiqoLAy1uHIojrkHK3KMlyqP0ydwWM9r8xRIYhHFJBX6jLGuIHaVa8oTy1SSKM0yGsCbrdXKRSPKUSKYcWYuf5s5gHNn0F0PJ6TtH8yXP8rWJCXNVaKokUbFEqFu5c6Zec5tpiuplTIBnGzdoWxn96qk-APOnXRTAK93zTgv3WGLrM184_pQzApEVsQBHDfesxvJ1vsC4Ht-tTfU_RZ0J6_93brPs39-8xXcGfUH5cf3ww_P4S6mf4XnIbETOFwvN-YFHKz05qWfTL8ATywnpg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Colorectal-Targeted+Dietary+Supplement+Tablets+Containing+Natural+Purple+Rice+Bran+Oil+as+a+Colorectal+Chemopreventive&rft.jtitle=Nutrients&rft.au=Sirithunyalug%2C+Busaban&rft.au=Saenjum%2C+Chalermpong&rft.au=Charumanee%2C+Suporn&rft.au=Sivamaruthi%2C+Bhagavathi+Sundaram&rft.date=2018-04-04&rft.eissn=2072-6643&rft.volume=10&rft.issue=4&rft_id=info:doi/10.3390%2Fnu10040444&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6643&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6643&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6643&client=summon